Table 3.
Tested Markers |
Negative Population |
Positive Population |
||
---|---|---|---|---|
Phenotype | Generic Name | Phenotype | Generic Name | |
CD45 | CD45-, SSClo | Erythroid Precursors | CD19-, CD56-, CD45br, SSClo | T Cells |
CD19 | CD45br, CD56+, SSClo | NK Cells | CD19+, CD45br, SSClo | B Cells |
CD27 | CD45+, CD117br | Mast Cells | CD19-, CD56-, CD45br, SSClo | T Cells |
CD81 | CD45dim,SSChi | Granulocytes | CD19-, CD56-, CD45br, SSClo | T Cells |
CD56 | CD19+, CD56-, CD45br, SSClo | B Cells | CD19-, CD56+, CD45br, SSClo | NK Cells |
CD117 | CD19-, CD56-, CD45br, SSClo | T Cells | CD27, CD117br | Mast Cells |
CD138 | CD19+, CD56-, CD45br, SSClo | B Cells | CD45dim, CD81+ | Spiked Controla |
CD38 | CD19+, CD81dim | Mature B | CD19+, CD81+ | B-progenitors |
cKappa | CD19+, CD45br, cLambda+, SSClo | cLambda+ B Cells | CD19+, CD45br, cLambda-, SSClo | cLambda- B Cells |
cLambda | CD19+, CD45br, cKappa+, SSClo | cKappa+ B cells | CD19+, CD45br, cKappa-, SSClo | cKappa- B cells |
A procedural control for immunophenotyping, CD-Chex CD103™ Plus (Streck, Omaha, NE), which also expresses CD138 is spiked into the bone marrow sample and used as the positive population. Modified from (Soh et al., 2017)